…
Singular Health Group Ltd, operates as a healthcare technology company in Australia. The company Volumetric Rendering Platform, a proprietary technology that enhances the visualization of patient anatomy and health issues by converting 2D images from CT, MRI, and PET scans into 3D models. It also provides Medical File Transfer Protocol, a technology that streamlines the access, sharing, and storage of medical images, such as CT, MRI, and PET scans across electronic devices and healthcare providers. In addition, the company offers AI in the Cloud that enhances medical imaging by integrating AI models. Further, it provides 3DICOM MD for healthcare professionals; 3DICOM EDU and XR for academics and researchers; and 3DICOM Patient for patients. Additionally, the company is involved in development and commercialization of the 3DICOM platform; enterprise healthcare imaging/interoperability solutions; education applications; and associated regulatory and product-development activities. Singular Health Group Ltd was incorporated in 2020 and is based in Leederville, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Singular Health Group Ltd is an Australian medical technology company that develops AI-powered software for medical imaging and treatment planning used by hospitals and clinics; long-term growth drivers include broader AI adoption in healthcare, demographic trends increasing imaging demand, and market and regulatory expansion. Investors may find the company attractive for its technology focus and potential for scalable recurring revenue if clinical adoption and commercialization progress.
Principal risks include commercialization and execution risk, regulatory approval and reimbursement uncertainty, competition and the need for additional funding.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -6.34M | -6.26M | -2.88M | -5.39M | -5.99M |
| Net income | -6.34M | -6.38M | -4.92M | -5.39M | -5.99M |
| Selling general administrative | - | 0.87M | 0.82M | 4.22M | 4.54M |
| Selling and marketing expenses | - | 0.28M | 0.29M | - | 0.29M |
| Gross profit | -4.02M | -0.09M | 0.52M | 0.52M | 0.05M |
| Reconciled depreciation | - | 0.13M | 0.20M | 0.39M | 0.26M |
| Ebit | -6.77M | -6.40M | -3.09M | -4.74M | -5.97M |
| Ebitda | -6.69M | -6.27M | -2.58M | -3.83M | -5.71M |
| Depreciation and amortization | 0.08M | 0.13M | 0.51M | - | 0.26M |
| Operating income | -6.77M | -6.20M | -2.86M | -4.90M | -5.97M |
| Other operating expenses | 8.20M | 6.76M | 3.80M | 0.06M | 6.34M |
| Interest expense | 0.01M | 0.01M | 0.10M | 0.46M | 0.01M |
| Tax provision | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Interest income | - | 0.14M | 0.01M | 0.49M | 0.01M |
| Net interest income | - | 0.13M | 0.22M | -0.46M | -0.01M |
| Extraordinary items | - | -0.11M | -2.05M | - | - |
| Income tax expense | - | - | 2.05M | - | 0.32M |
| Total revenue | 1.43M | 0.56M | 0.93M | 1.03M | 0.05M |
| Total operating expenses | 2.75M | 6.11M | 3.38M | - | 6.34M |
| Cost of revenue | 5.45M | 0.64M | 0.42M | 0.51M | - |
| Total other income expense net | 0.43M | -0.06M | -0.01M | 0.43M | 0.30M |
| Net income from continuing ops | - | -6.26M | -2.88M | -4.68M | -5.99M |
| Net income applicable to common shares | - | -6.38M | -4.92M | -5.39M | -5.99M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 11.24M | 14.21M | 2.35M | 3.00M | 2.14M |
| Intangible assets | - | - | - | 0.27M | 0.45M |
| Other current assets | 0.09M | 0.07M | 0.68M | - | - |
| Total liab | 0.70M | 1.11M | 0.91M | 2.94M | 0.39M |
| Total stockholder equity | 10.54M | 13.10M | 1.44M | 0.06M | 1.75M |
| Other current liab | 0.17M | 0.46M | 0.64M | 0.01M | 0.19M |
| Common stock | 32.66M | - | 16.43M | 11.98M | 9.53M |
| Capital stock | - | 29.92M | - | 11.98M | 9.53M |
| Retained earnings | -30.22M | -23.88M | -20.90M | -16.14M | -11.15M |
| Good will | - | - | - | 0.78M | - |
| Other assets | - | - | 0.00M | - | - |
| Cash | 2.36M | 13.68M | 1.45M | 0.69M | 1.14M |
| Total current liabilities | 0.61M | 1.11M | 0.91M | 2.70M | 0.37M |
| Current deferred revenue | - | - | 0.00M | - | - |
| Net debt | -2.25M | - | -1.23M | 1.08M | -1.05M |
| Short term debt | 0.02M | - | 0.22M | 2.24M | 0.07M |
| Short long term debt | - | - | - | 1.77M | 0.00M |
| Short long term debt total | 0.11M | - | 0.22M | - | 0.09M |
| Other stockholder equity | - | - | - | 4.22M | 3.37M |
| Property plant equipment | - | - | - | 0.87M | 0.13M |
| Total current assets | 11.01M | 14.06M | 2.20M | 0.98M | 1.31M |
| Long term investments | - | - | - | 0.23M | 0.24M |
| Net tangible assets | - | - | - | -0.98M | 1.29M |
| Short term investments | 7.70M | - | - | - | - |
| Net receivables | 0.86M | 0.06M | 0.06M | 0.07M | 0.14M |
| Long term debt | - | - | - | 0.14M | - |
| Inventory | - | - | - | 0.13M | - |
| Accounts payable | 0.42M | 0.26M | 0.05M | 0.16M | 0.12M |
| Accumulated other comprehensive income | 8.10M | - | 5.91M | - | 3.37M |
| Non currrent assets other | 0.01M | - | 0.11M | - | - |
| Non current assets total | 0.22M | 0.14M | 0.15M | 2.21M | 0.83M |
| Capital lease obligations | - | - | - | 0.31M | 0.08M |
| Long term debt total | - | - | - | 0.23M | 0.02M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | 0.09M | -0.00M | -0.63M | -0.01M |
| Change to liabilities | - | - | - | 0.70M | -0.01M |
| Total cashflows from investing activities | 5.37M | 0.09M | -0.00M | -0.64M | -0.02M |
| Net borrowings | - | -0.21M | -1.67M | 1.10M | -0.07M |
| Total cash from financing activities | 1.67M | 14.48M | 3.21M | 2.65M | -0.07M |
| Change to operating activities | - | - | - | 0.00M | 0.04M |
| Net income | -6.34M | -6.38M | -4.92M | -5.39M | -5.99M |
| Change in cash | -11.32M | 12.22M | 0.76M | -0.45M | -3.00M |
| Begin period cash flow | 13.68M | 1.46M | 0.69M | 1.14M | 4.14M |
| End period cash flow | 2.36M | 13.68M | 1.46M | 0.69M | 1.14M |
| Total cash from operating activities | -5.30M | -2.34M | -2.44M | -2.46M | -2.91M |
| Issuance of capital stock | - | 14.72M | 5.17M | 1.55M | - |
| Depreciation | 0.08M | 0.13M | 0.20M | 0.39M | 0.26M |
| Other cashflows from investing activities | 0.17M | 0.12M | 0.07M | -0.61M | -0.01M |
| Change to inventory | - | - | -0.18M | - | - |
| Change to account receivables | -0.63M | -0.13M | -0.00M | -0.10M | 0.07M |
| Sale purchase of stock | - | 14.72M | 5.17M | 1.55M | 0.00M |
| Other cashflows from financing activities | -0.01M | -0.21M | -0.29M | 0.42M | -0.07M |
| Change to netincome | - | - | - | 1.94M | 2.72M |
| Capital expenditures | 0.14M | 0.03M | 0.07M | 0.02M | 0.01M |
| Change in working capital | -1.17M | -0.16M | -0.16M | 0.42M | 0.38M |
| Stock based compensation | - | 3.28M | - | - | - |
| Other non cash items | 2.13M | 0.78M | 2.65M | - | - |
| Free cash flow | -5.45M | -2.37M | -2.51M | -2.53M | -0.01M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| SHG Singular Health Group Ltd |
0.01 2.50% |
0.20 | - | - | 37.76 | 6.50 | 40.98 | -1.47 |
| PME Pro Medicus Ltd |
-4.52 2.18% |
202.79 | 81.98 | 106.38 | 83.13 | 43.70 | 74.38 | 95.34 |
| 4DX 4DMEDICAL Ltd |
-0.06 2.53% |
2.31 | - | - | 205.57 | 8.53 | 170.03 | -7.29 |
| CGS Cogstate Ltd |
0.12 3.30% |
3.76 | 33.80 | 27.86 | 9.59 | 6.95 | 6.35 | 19.27 |
| AYA ARTRYA Ltd |
-0.14 3.91% |
3.44 | - | - | 20505.14 | 7.00 | 16927.51 | 0.33 |
Singular Health Group Ltd, operates as a healthcare technology company in Australia. The company Volumetric Rendering Platform, a proprietary technology that enhances the visualization of patient anatomy and health issues by converting 2D images from CT, MRI, and PET scans into 3D models. It also provides Medical File Transfer Protocol, a technology that streamlines the access, sharing, and storage of medical images, such as CT, MRI, and PET scans across electronic devices and healthcare providers. In addition, the company offers AI in the Cloud that enhances medical imaging by integrating AI models. Further, it provides 3DICOM MD for healthcare professionals; 3DICOM EDU and XR for academics and researchers; and 3DICOM Patient for patients. Additionally, the company is involved in development and commercialization of the 3DICOM platform; enterprise healthcare imaging/interoperability solutions; education applications; and associated regulatory and product-development activities. Singular Health Group Ltd was incorporated in 2020 and is based in Leederville, Australia.
| Name | Title | Year Born |
|---|---|---|
| Mr. Thomas Hanly B.A. | MD, CEO & Director | NA |
| Mr. James Hill | Chief Operating Officer | NA |
| Dr. Kwang Guan Tay Ph.D. | Exec. Director of Innovation and Education & Director | NA |
| Mr. Steven Douglas Wood B.Com, B.Com., BCom., C.A., CA | Company Sec. | NA |
| Mr. Thomas Morrell | Chief Technology Officer | NA |
| Mr. Denning Chong | Co-Founder, MD, CEO & Director | NA |
| Mr. Steven Douglas Wood B.Com, B.Com., BCom., C.A., CA | Company Secretary | NA |
| Ms. Kyla Garic B.Com., C.A. | Chief Financial Officer | NA |
| Mr. Denning Chong | Co-Founder, MD, CEO & Director | NA |
| Mr. Steven Douglas Wood B.Com, B.Com., BCom., C.A., CA | Company Secretary | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.